|
DEM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.805700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.434390E-01 |
| Normal-vs-Stage2 |
6.602400E-02 |
| Normal-vs-Stage3 |
1.520240E-02 |
| Normal-vs-Stage4 |
9.042200E-02 |
| Stage1-vs-Stage2 |
3.504400E-01 |
| Stage1-vs-Stage3 |
7.015800E-02 |
| Stage1-vs-Stage4 |
9.698300E-02 |
| Stage2-vs-Stage3 |
5.722400E-01 |
| Stage2-vs-Stage4 |
4.002600E-01 |
| Stage3-vs-Stage4 |
6.980000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.243800E-02 |
| Normal-vs-AfricanAmerican |
3.125200E-01 |
| Normal-vs-Asian |
5.199800E-01 |
| Caucasian-vs-AfricanAmerican |
4.719000E-01 |
| Caucasian-vs-Asian |
7.709400E-01 |
| AfricanAmerican-vs-Asian |
5.937000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.042240E-02 |
| Normal-vs-Female |
4.983600E-01 |
| Male-vs-Female |
3.440000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.247550E-01 |
| Normal-vs-Extreme_Weight |
3.166200E-02 |
| Normal-vs-Obese |
6.488000E-02 |
| Normal-vs-Extreme_Obese |
1.770160E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.385000E-01 |
| Normal_Weight-vs-Obese |
9.405000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.333600E-01 |
| Extreme_Weight-vs-Obese |
9.937400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.501800E-01 |
| Obese-vs-Extreme_Obese |
7.704000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.349800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.548800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.761300E-03 |
| Normal-vs-Age(81-100Yrs) |
5.386100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.662200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.807400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.280000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.195700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.447800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.755800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.931800E-01 |
| Normal-VS-Type2 PRCC |
2.815500E-03 |
| Normal-VS-KIRP CIMP |
7.90656429217051E-12 |
| Normal-VS-Unclassified PRCC |
5.033000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.782300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.27980000433448E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
6.585600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.600100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.075810E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.90150000004097E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.615400E-03 |
| Normal-vs-N1 |
5.235800E-02 |
| Normal-vs-N2 |
1.01910000438465E-08 |
| N0-vs-N1 |
5.575000E-01 |
| N0-vs-N2 |
3.171700E-04 |
| N1-vs-N2 |
5.073800E-02 |
|
|
